THIRD HARMONIC BIO INC (THRD) Stock Income Statement
NASDAQ:THRD - Nasdaq - US88427A1079 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 66.30M | 58.87M | 43.95M | 37.71M | 19.00M | |||
| Research and Development | 40.92M | 36.50M | 23.96M | 24.41M | 15.75M | |||
| Selling, General, and Administrative Expenses | 25.38M | 22.37M | 19.99M | 13.30M | 3.26M | |||
| Operating Income | -66.30M | -58.87M | -43.95M | -37.71M | -19.00M | |||
| Interest Income/Expense | 12.86M | 13.41M | 13.11M | N/A | N/A | |||
| Other Income/Expense | -13.00K | -6.00K | 22.00K | 2.55M | -10.61M | |||
| Income Before Taxes | -53.45M | -45.47M | -30.82M | -35.16M | -29.61M | |||
| Net Income | -53.45M | -45.47M | -30.82M | -35.16M | -29.61M | |||
| EBITDA | -66.25M | -58.82M | -43.92M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.24 | -1.09 | -0.78 | -0.89 | -0.77 | |||
| Non GAAP EPS | -1.42 | -1.27 | -0.95 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD